160
Participants
Start Date
April 20, 2018
Primary Completion Date
April 1, 2026
Study Completion Date
April 1, 2026
[C-11]PiB-PET/MRI
All study participants will undergo brain imaging with \[C-11\]PiB-PET/MRI. \[C-11\]PiB is a PET imaging agent used primarily to measure the amount of abnormal protein (called beta-amyloid) in the brain. The investigator will also use this tracer to evaluate regional cerebral blood flow.
RECRUITING
University of Alabama at Birmingham Medical Center, Birmingham
National Institute on Aging (NIA)
NIH
University of Alabama at Birmingham
OTHER